Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00826449 · COMPLETED

Trial details

NCT number: NCT00826449
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-Small Cell Lung Cancer

Start date: 2009-02-01
Primary completion: 2014-06-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.